Most clinical anti-EGFR antibodies do not neutralize both wtEGFR and EGFRvIII activation in glioma

Sameer A. Greenall, Mathew McKenzie, Ekatarina Seminova, Olan Dolezal, Lesley Pearce, John Bentley, Mani Kuchibhotla, Shengnan C. Chen, Kerrie L. McDonald, Harley I. Kornblum, Raelene Endersby, Timothy E. Adams, Terrance G. Johns

Research output: Contribution to journal › Article › peer-review